Mitochondrial phosphate-carrier deficiency mimicking infantile-onset Pompe disease


Küçükcongar Yavaş A., Basan H., Dinçer S., Bilginer Gürbüz B., Kasapkara Ç. S.

American Journal of Medical Genetics, Part A, vol.194, no.9, 2024 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 194 Issue: 9
  • Publication Date: 2024
  • Doi Number: 10.1002/ajmg.a.63643
  • Journal Name: American Journal of Medical Genetics, Part A
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Applied Science & Technology Source, BIOSIS, CAB Abstracts, EMBASE, MEDLINE
  • Keywords: adenosine triphosphate synthesis, cardiomyopathy, elevated creatinine kinase, muscular hypotonia
  • Ankara Yıldırım Beyazıt University Affiliated: No

Abstract

The mitochondrial phosphate carrier is critical for adenosine triphosphate synthesis by serving as the primary means for mitochondrial phosphate import across the inner membrane. Variants in the SLC25A3 gene coding mitochondrial phosphate carrier lead to failure in inorganic phosphate transport across mitochondria. The critical dependence on mitochondria as an energy source is especially evident in tissues with high-energy demands such as the heart, muscle; defects in the mitochondrial energy production machinery underlie a wide range of primary mitochondrial disorders that present with cardiac and muscle diseases. The characteristic clinical picture of a prominent early-onset hypertrophic cardiomyopathy and lactic acidosis may be an indication for analysis of the SLC25A3 gene. Here, described a patient with suspicion of infantile Pompe disease due to involvement of heart and muscle and high-level of plasma creatinine kinase but finally diagnosed mitochondrial phosphate-carrier deficiency.